Your browser doesn't support javascript.
loading
The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia.
Kisely, Steve; Dangelo-Kemp, Dante; Taylor, Mark; Liu, Dennis; Graham, Simon; Hartmann, Jodie; Colman, Sam.
Afiliación
  • Kisely S; School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia.
  • Dangelo-Kemp D; Addiction and Mental Health Service, Metro South Health, Woolloongabba, QLD, Australia.
  • Taylor M; Covance Market Access Services, Sydney, NSW, Australia.
  • Liu D; School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia.
  • Graham S; Toowong Specialist Clinic, Toowong, QLD, Australia.
  • Hartmann J; Northern Mental Health Service, Salisbury, SA, Australia.
  • Colman S; Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
Aust N Z J Psychiatry ; 56(6): 642-647, 2022 06.
Article en En | MEDLINE | ID: mdl-34240634
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / COVID-19 Tipo de estudio: Observational_studies Límite: Adult / Humans País/Región como asunto: Oceania Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / COVID-19 Tipo de estudio: Observational_studies Límite: Adult / Humans País/Región como asunto: Oceania Idioma: En Año: 2022 Tipo del documento: Article